To get the latest experience from our website, please upgrade your browser.
The European Medicines Agency (EMA) recommended manufacturers of Invokana (canagliflozin) and other sodium glucose cotransporter 2 (SGLT2) inhibitors add warnings for increased lower-limb amputations to prescribing information. On Feb. 10, 2017, the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) looked at [...]Read More
A government report revealed limitations in the U.S. Food and Drug Administration’s adverse event reporting system led to a 23-year delay in warning the public about serious risks linked to [...]
Ethicon will defend against claims that its hernia mesh caused serious injuries in a trial slated to begin in 2018, according to court documents. The trial is the first Ethicon [...]
Patients undergoing incisional hernia repair with hernia mesh may have a lower risk for hernia recurrence, but complications can occur up to five years after surgery, a new study says. [...]
President Donald Trump takes a few prescription medications including Propecia (finasteride), a hair loss drug linked to side effects, the New York Times reported. Dr. Harold N. Bernstein, Trump’s personal [...]
After its initial $1 billion dollar settlement offer in 2014, Stryker Corporation and Howmedica Osteonics Corp. reached a new agreement to compensate additional hip implant patients, according to a press [...]